Acadian Asset Management
EPIX

Acadian Asset Management’s ESSA Pharma EPIX Stock Holding History

Acadian Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,687
Closed -$28K – 1674
2024
Q4 		$28K Buy
+15,687
New +$50K ﹤0.01% 1519
2023
Q4 		– Sell
-15,903
Closed -$48K – 1704
2023
Q3 		$48K Hold
15,903
– – ﹤0.01% 1435
2023
Q2 		$42K Hold
15,903
– – ﹤0.01% 1549
2023
Q1 		$47K Buy
+15,903
New +$46.7K ﹤0.01% 1519
2022
Q4 		– Sell
-72,046
Closed -$129K – 1812
2022
Q3 		$129K Buy
+72,046
New +$190K ﹤0.01% 1301
2016
Q1 		– Sell
-255
Closed -$23K – 1396
2015
Q4 		$23K Sell
255
-640
-72% -$66.8K ﹤0.01% 1158
2015
Q3 		$113K Buy
+895
New +$125K ﹤0.01% 974

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return

Acadian Asset Management's EPIX Position: Q1 2025 in Review

Acadian Asset Management sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 15,687 shares — an estimated $28K sold.

Acadian Asset Management first reported a position in EPIX in Q3 2015 and held it in 7 quarters. The position peaked at $129K in Q3 2022. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

  • Acadian Asset Management reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
  • Acadian Asset Management sold 15,687 ESSA Pharma shares in Q1 2025, an estimated $28K.
  • Acadian Asset Management first reported a position in ESSA Pharma in Q3 2015 and held it in 7 quarters.
  • Acadian Asset Management's ESSA Pharma position peaked at $129K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on Acadian Asset Management's 13F filing for Q1 2025, filed 21 May 2025.